Skip to main content

Series A Biotechnology Companies

Explore 774 biotechnology startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
774
Total Funding
$1.0B
Avg Funding
$40.9M
Cities
21

Export 774 Series A Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Sarasota, United States
$8.5M
raised

Omeza is a hospital and healthcare company that provides wound care, venous leg ulcers, omega 3, and innovation.

Apr 2026
Series A

Founder Contacts

41,000+ verified contacts

Geneva, Switzerland
$20.5M
raised

Planetary is a food-tech company that builds and operates industrial fermentation facilities to produce sustainable, bio-based ingredients.

Apr 2026
Series A

Founder Contacts

41,000+ verified contacts

Shinjuku, Japan
$13.0M
raised

Sonia Therapeutics is a medical equipment manufacturing company that develops a device for ultrasound treatment system.

Apr 2026
Series A

Founder Contacts

41,000+ verified contacts

Boston, United States
$300.0M
raised

Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.

Apr 2026
Series A

Founder Contacts

41,000+ verified contacts

Woburn, United States
$54.0M
raised

Vivatides Therapeutics develops RNA treatments to help improve patients' lives using biotechnology research.

Apr 2026
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$100.0M
raised

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

Apr 2026
Series A

Founder Contacts

41,000+ verified contacts

Newton, United States
$50.0M
raised

Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

Apr 2026
Series A

Founder Contacts

41,000+ verified contacts

Paris, France
$23.1M
raised

Generare is a biotech startup that discovers next-generation medicines and high-value molecules hiding in soil bacteria.

Apr 2026
Series A

Founder Contacts

41,000+ verified contacts

New York, United States
$60.0M
raised

Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company that develops psychedelic and related drugs to treat mental illnesses.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom
$87.1M
raised

Immutrin is a biotech developing next‑generation antibody therapies to clear amyloid deposits and reverse amyloidosis.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Orange, Australia
$13.3M
raised

Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

Bozeman, United States

ALERCELL AI-powered epigenetic diagnostic platform detecting leukemia up to 41 months before clinical symptoms.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

Belmont, United States
$21.0M
raised

Oryon Cell treatments is a clinical-stage biotechnology business exploring autologous cell treatments for neurodegenerative illnesses.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

Schönefeld, Germany
$11.5M
raised

Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

Edinburgh, United Kingdom
$8.3M
raised

Bioliberty are a medtech start-up developing rehabilitation solutions for degenerative and traumatic conditions.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
London, United Kingdom
$77.5M
raised

R1 Therapeutics is a clinical-stage biopharmaceutical company that develops first-in-class treatments for kidney disease patients.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

San Diego, United States
$16.1M
raised

VST Bio is a biotechnology company that offers and develops treatment for vascular diseases.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

Freiburg, Germany
$11.3M
raised

BioCopy developed an innovative, patented technique to copy biomolecules analogous to a photocopier.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$40.0M
raised

Vima Therapeutics operates as a biotechnology company.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

Santa Monica, United States
$13.0M
raised

This company is a California-based biotechnology firm developing novel small molecule lipids, referred to as oxysterols.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Mountain View, United States

Metanovas develops drugs, dietary supplements, functional foods, and cosmetics using AI technology.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$19.0M
raised

Tacit Therapeutics created RNA-targeting treatments for devastating diseases.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$15.0M
raised

Shellworks is a biomaterials company that develops and manufactures materials that offers alternative to conventional plastics.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

Cardiff, United Kingdom
$9.3M
raised

Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

New York, United States
$50.0M
raised

Prolium is a biotechnology company, which specializes in providing breakthrough therapies to the patients with autoimmune diseases.

Mar 2026
Series A

Founder Contacts

41,000+ verified contacts

Showing 76 to 100 of 774 companies

Ready to Connect with Series A Biotechnology Startups?

Get verified founder emails, funding details, and company data for 774 series a biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked